A citywide initiative in Mexico City to prescribe ivermectin to COVID-19 patients resulted in a plunge in hospitalizations and deaths, two studies found.
At the time, the head of the Mexico City Ministry of Health, Oliva López, said told reporters her agency had determined "That there is enough evidence to use in people positive for SARS-CoV-2, even without symptoms, some drugs such as ivermectin and azithromycin."
The Mexican government then began a study to track the impact of the early treatment of COVID with ivermectin on the city's population.
The government's findings were corroborated by Dr. Juan J. Chamie-Quintero, a senior data analyst at private Colombian university EAFIT. He found that excess deaths in the city dropped sharply only a few weeks after the ivermectin treatments began.
In the 24 Peruvian states that adopted early use of ivermectin treatment, excess deaths plummeted on average by 59% just 30 days after the peak death rate.
Worldwide, more than 50 peer-reviewed studies have shown the effectiveness of ivermectin as a treatment and prophylaxis against COVID-19.
A study by the American Journal of Therapeutics that analyzed 18 randomized controlled treatment trials found ivermectin elicited "Large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance" in COVID patients.
https://www.wnd.com/2021/05/covid-deaths-plunge-major-world-city-introduced-ivermectin/
No comments:
Post a Comment